Phase III, randomized controlled trial in girls 9-15 years old to evaluate lot consistency of a novel nine-valent human papillomavirus L1 virus-like particle vaccine.
| Data(s) |
19/05/2016
19/05/2016
2015
|
|---|---|
| Identificador |
LUXEMBOURG, A. et al. Phase III, randomized controlled trial in girls 9-15 years old to evaluate lot consistency of a novel nine-valent human papillomavirus L1 virus-like particle vaccine. Human Vaccines & Immunotherapeutics, v. 11, n. 6, p. 1306-1312, 2015. 2164-5515 http://arca.icict.fiocruz.br/handle/icict/14399 /dx.doi.org/10.1080/21645515.2015.1009819 |
| Idioma(s) |
eng |
| Publicador |
Taylor & Francis: STM, Behavioural Science and Public Health Titles |
| Direitos |
open access |
| Tipo |
Article |
